Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.56 - $3.25 $492,702 - $2.86 Million
-879,826 Reduced 55.0%
720,000 $637,000
Q1 2022

May 16, 2022

BUY
$2.46 - $5.92 $2.89 Million - $6.95 Million
1,173,974 Added 275.68%
1,599,826 $4.81 Million
Q4 2021

Feb 14, 2022

BUY
$4.26 - $23.33 $95,394 - $522,428
22,393 Added 5.55%
425,852 $2.2 Million
Q3 2021

Nov 16, 2021

BUY
$18.12 - $28.5 $219,614 - $345,420
12,120 Added 3.1%
403,459 $9.57 Million
Q2 2021

Aug 16, 2021

SELL
$14.16 - $19.53 $1.18 Million - $1.63 Million
-83,661 Reduced 17.61%
391,339 $7.6 Million
Q1 2021

May 17, 2021

BUY
$15.9 - $18.61 $7.55 Million - $8.84 Million
475,000 New
475,000 $8.7 Million

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55.6M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.